Premium
Convincing New Providers to Offer Medical Abortion: What Will It Take?
Author(s) -
Coeytaux Francine,
Moore Kirsten,
Gelberg Lillian
Publication year - 2003
Publication title -
perspectives on sexual and reproductive health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.818
H-Index - 93
eISSN - 1931-2393
pISSN - 1538-6341
DOI - 10.1111/j.1931-2393.2003.tb00086.x
Subject(s) - abortion , pregnancy , biology , genetics
Less than one year after the Food and Drug Administra- tion (FDA) approved Mifeprex (mifepristone), commonly known as the "abortion pill," an article in the Los Angeles Times 1 predicted a bleak future for the drug in the United States. The reporter had contacted 53 clinics in California and found that fewer than half offered medical abortion to their patients. Reasons commonly cited for not offering the service included cost, the need for training and the obli- gation of instituting new procedures for counseling and follow-up care. Several providers also seemed to believe that medical abortion was inherently less reliable or acceptable